According to Swedish Orphan Biovitrum's latest financial reports and stock price the company's current Operating Margin is 22.32%. At the end of 2022 the company had an Operating Margin of 17.67%.
Year | Operating Margin | Change |
---|---|---|
2022 | 17.67% | -16.7% |
2021 | 21.22% | -23.21% |
2020 | 27.63% | -7.3% |
2019 | 29.81% | -11.61% |
2018 | 33.72% | 43.27% |
2017 | 23.54% | 16.88% |
2016 | 20.14% | 641.23% |
2015 | 2.72% | -122.23% |
2014 | -12.22% | 115.52% |
2013 | -5.67% | 3.76% |
2012 | -5.46% | -71.84% |
2011 | -19.41% | 300.48% |
2010 | -4.85% | -293.77% |
2009 | 2.50% | -107.79% |
2008 | -32.09% | -610.44% |
2007 | 6.29% | -19.83% |
2006 | 7.84% | -141.31% |
2005 | -18.98% | -524.76% |
2004 | 4.47% | -120.03% |
2003 | -22.31% | -910.13% |
2002 | 2.75% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.